Treating sleep apnea in veterans with substance use disorder and PTSD in residential care
Tests airway pressure treatment for sleep apnea in veterans with substance use disorder and PTSD.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- San Diego, United StatesSee the site
- Trial code
- Registry title
- OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- Status
- Recruiting
- People taking part
- 194 people, planned
- Started
- 2 Jan 2023
- Expected to end
- 31 May 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Positive Airway Pressure Device
- Record updated
- 19 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for U.S. Veterans with obstructive sleep apnea, substance use disorder and PTSD who are on a residential treatment unit. It compares sleep apnea treatment with a breathing device (PAP) on the unit to a waitlist group.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Obstructive sleep apnea with an Apnea Hypopnea Index (AHI) of 5 per hour. Current substance use disorder with at least 20 days of substance use in the last 90 days. Full PTSD diagnosis, with trauma at least one month ago. Must be on the PTSD track of the Substance Abuse Residential Rehabilitation Treatment Program (SARRPT) unit.
- Earlier treatment
- People who already use a positive airway pressure (PAP) device when they arrive cannot join. People diagnosed with OSA before but not using PAP can join.
- Biomarker or test result
- Apnea Hypopnea Index (AHI) 5 per hour on a sleep test.
Main reasons for not taking part
- Central sleep apnea (AHI>=5 and > 50% central apneas)
- Already using a PAP device on arrival
- Unit medical staff advise against joining
- Severe memory or thinking problems (MOCA < 26)
- History of psychosis or mania not caused by substance use
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- a Veteran of the U.S. military or Reserve/National Guard member
- have an Apnea Hypopnea Index (AHI) 5 per hour
- experienced trauma that occurred in childhood or adulthood; at least one month post-trauma
- have current DSM-5 diagnoses of substance use disorder (SUD) via Structured Clinical Interview for DSM-Substance Use Disorders (SCID-SUD) module with a minimum 20 days of substance use in the last 90 days (Timeline Follow-back)
- Full post-traumatic stress disorder (PTSD) diagnosis via clinician administered post-traumatic stress disorder (PTSD) scale
- are literate in English
- are on the post-traumatic stress disorder (PTSD) track of the Substance Abuse Residential Rehabilitation Treatment Program (SARRPT) unit
- are capable of giving informed consent
Who cannot take part
- arrives on the Substance Abuse Residential Rehabilitation Treatment Program (SARRPT) unit already using a positive airway pressure (PAP) device (Veteran's previously diagnosed with OSA, but not using positive airway pressure (PAP) therapy will be eligible)
- the Substance Abuse Residential Rehabilitation Treatment Program (SARRPT) medical staff advises against the study based on medical history and physical examination; d) history of severe cognitive impairment (via Montreal Cognitive Assessment (MOCA) < 26)
- history of psychosis or mania independent of substance use will be excluded because the presence of these disorders can impede therapy progress
- have central sleep apnea (Apnea Hypopnea Index (AHI)>=5 and > 50% central apneas)
Where in United States
- VA San Diego Healthcare System, San Diego, CASan Diego, United StatesContact: Peter Colvonen, PhDTaking people
About the trial
What the trial wants to find out
Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more severe than outpatient settings. Obstructive sleep apnea (OSA) is highly comorbid with both disorders and untreated OSA is associated with worse functional impairment across multiple domains, worse quality of life, worse PTSD, higher suicidal ideation, and higher substance use and relapse rates. Treating OSA with evidence-based positive airway pressure (PAP) in Veterans with SUD/PTSD on a residential unit is a logical way to maximize treatment adherence and treatment outcomes. This study compares OSA treatment while on a SUD/PTSD residential unit to a waitlist control group. The investigators hypothesize that treating OSA on the residential unit, compared to the waitlist control, will have better functional, SUD, and PTSD outcomes.
The 2 groups in the trial
- PAP Treatment on SARRTP UnitTreatment being tested
Veterans will receive Positive Airway Pressure device while on the 28-day SARRTP Unit.
Treatment: Positive Airway Pressure Device
- Waitlist ControlNo study treatment, for comparison
Veterans will not receive PAP device until after 3-month Follow Up.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Examining Early Intervention Obstructive Sleep Apnea Treatment on Long-Term Outcomes in Veterans With SUD/PTSD in a Residential Treatment Program
- Plain-language title
- Treating sleep apnea in veterans with substance use disorder and PTSD in residential careGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 19 October 2026